Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can MRI Curb Chemo Overtreatment in Breast Cancer?

2.

Lymph node transfer reduces arm swelling after breast cancer surgery, study shows

3.

EHA: European Hematology Association

4.

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

5.

Stem Cell Selection Unneeded for SSc Transplant Therapy?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot